Hudson Bay Capital Management LP - 31 Mar 2025 SCHEDULE 13G Report for Drugs Made In America Acquisition Corp. Ordinary Shares, $0.0001 par value (DMAA)

Filing Manager
Hudson Bay Capital Management LP
Reporting Manager
Hudson Bay Capital Management LP
Security
Drugs Made In America Acquisition Corp. Ordinary Shares, $0.0001 par value
Symbol
DMAA
Shares outstanding
33,519,553 shares
Disclosed Ownership
1,800,000 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
14 May 2025, 13:37:16 UTC
Date of event
31 Mar 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Hudson Bay Capital Management LP disclosed 5.4% ownership in Drugs Made In America Acquisition Corp. Ordinary Shares, $0.0001 par value (DMAA) on 31 Mar 2025."

Quick Takeaways

  • Hudson Bay Capital Management LP filed SCHEDULE 13G for Drugs Made In America Acquisition Corp. Ordinary Shares, $0.0001 par value (DMAA).
  • Disclosed ownership: 5.4%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 May 2025, 13:37.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Hudson Bay Capital Management LP 5.4% 1,800,000 0 1,800,000 /s/ Sander Gerber Sander Gerber, Authorized Signatory
Sander Gerber 5.4% 1,800,000 0 1,800,000 /s/ Sander Gerber Sander Gerber, Individually

Sponsored